NAMM
IDXX icon

NorthStar Asset Management (Massachusetts)’s Idexx Laboratories IDXX Stock Holding History

NorthStar Asset Management (Massachusetts)’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.27M Sell
11,901
-793
-6% -$445K 1.84% 20
2026
Q1 		$7.13M Sell
12,694
-3,591
-22% -$2.3M 2.19% 16
2025
Q4 		$11M Sell
16,285
-2,277
-12% -$1.55M 2.85% 14
2025
Q3 		$11.9M Sell
18,562
-430
-2% -$261K 3.08% 13
2025
Q2 		$10.2M Buy
18,992
+27
+0.1% +$12.9K 2.82% 15
2025
Q1 		$7.96M Buy
18,965
+122
+0.6% +$53K 2.36% 18
2024
Q4 		$7.79M Sell
18,843
-61
-0.3% -$26.8K 2.05% 23
2024
Q3 		$9.55M Buy
18,904
+158
+0.8% +$76.8K 2.35% 20
2024
Q2 		$9.13M Buy
18,746
+386
+2% +$194K 2.33% 20
2024
Q1 		$9.91M Sell
18,360
-255
-1% -$139K 1.74% 20
2023
Q4 		$10.3M Sell
18,615
-108
-0.6% -$50.7K 2.99% 15
2023
Q3 		$8.19M Buy
18,723
+12
+0.1% +$5.98K 2.62% 18
2023
Q2 		$9.4M Buy
18,711
+239
+1% +$115K 2.77% 16
2023
Q1 		$9.24M Sell
18,472
-2,259
-11% -$1.08M 2.84% 16
2022
Q4 		$8.46M Buy
20,731
+67
+0.3% +$26K 2.82% 16
2022
Q3 		$6.73M Buy
20,664
+486
+2% +$179K 2.33% 18
2022
Q2 		$7.08M Sell
20,178
-2,498
-11% -$1.02M 2.33% 19
2022
Q1 		$12.4M Buy
22,676
+1,554
+7% +$817K 3.4% 12
2021
Q4 		$13.9M Buy
21,122
+676
+3% +$424K 3.5% 11
2021
Q3 		$12.7M Buy
20,446
+398
+2% +$267K 3.36% 12
2021
Q2 		$12.7M Buy
20,048
+1,232
+7% +$680K 3.38% 9
2021
Q1 		$9.21M Buy
+18,816
New +$9.43M 2.9% 14

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

NorthStar Asset Management (Massachusetts)'s IDXX Position: Q2 2026 in Review

NorthStar Asset Management (Massachusetts) reduced its Idexx Laboratories (IDXX) stake by 6.2% in Q2 2026, selling an estimated $445K and leaving 11,901 shares worth $6.27M. The position accounts for 1.84% of the portfolio, ranked #20.

NorthStar Asset Management (Massachusetts) first reported a position in IDXX in Q1 2021 and has held it in 22 quarters since. The position peaked at $13.9M in Q4 2021. 1,295 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • NorthStar Asset Management (Massachusetts) held 11,901 shares of Idexx Laboratories worth $6.27M as of Q2 2026.
  • NorthStar Asset Management (Massachusetts) sold 793 Idexx Laboratories shares in Q2 2026, an estimated $445K.
  • Idexx Laboratories made up 1.84% of NorthStar Asset Management (Massachusetts)'s portfolio in Q2 2026, its #20 holding.
  • NorthStar Asset Management (Massachusetts) first reported a position in Idexx Laboratories in Q1 2021 and has held it in 22 quarters since.
  • NorthStar Asset Management (Massachusetts)'s Idexx Laboratories position peaked at $13.9M in Q4 2021.
  • 1,295 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on NorthStar Asset Management (Massachusetts)'s 13F filing for Q2 2026, filed 28 Jul 2026.